Aware, Inc. (AWRE) At $3.39 Forms Bottom; Atrion (ATRI) Has 1.36 Sentiment

Aware, Inc. (NASDAQ:AWRE) Logo

Atrion Corp (ATRI) investors sentiment decreased to 1.36 in Q3 2019. It’s down -0.26, from 1.62 in 2019Q2. The ratio worsened, as 61 funds opened new and increased equity positions, while 45 sold and reduced their equity positions in Atrion Corp. The funds in our database now own: 1.21 million shares, down from 4.55 million shares in 2019Q2. Also, the number of funds holding Atrion Corp in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 14 Reduced: 31 Increased: 40 New Position: 21.

Aware, Inc. (AWRE) formed multiple bottom with $3.19 target or 6.00% below today’s $3.39 share price. Aware, Inc. (AWRE) has $72.85M valuation. It closed at $3.39 lastly. It is down 1.58% since January 16, 2019 and is uptrending. It has outperformed by 1.58% the S&P500. Some Historical AWRE News: 24/04/2018 – Aware Recognized as a Top Ten Multifactor Authentication Solution Provider by Enterprise Security Magazine; 22/04/2018 DJ Aware Inc, Inst Holders, 1Q 2018 (AWRE); 24/04/2018 – Aware Inc 1Q Loss/Shr 2c

Since August 9, 2019, it had 7 insider buys, and 0 selling transactions for $3.80 million activity. On Monday, November 18 Ronin Capital – LLC bought $45,716 worth of Aware, Inc. (NASDAQ:AWRE) or 15,500 shares. Another trade for 5,886 shares valued at $16,540 was bought by Eckel Robert A.

Investors sentiment increased to 1.29 in 2019 Q3. Its up 0.41, from 0.88 in 2019Q2. It increased, as 1 investors sold Aware, Inc. shares while 6 reduced holdings. 6 funds opened positions while 3 raised stakes. 4.77 million shares or 3.37% less from 4.94 million shares in 2019Q2 were reported. Bridgeway Management holds 0% or 114,479 shares in its portfolio. Northern Trust Corporation has 0% invested in Aware, Inc. (NASDAQ:AWRE) for 52,435 shares. Punch And Associates Inv Mgmt invested 0.22% in Aware, Inc. (NASDAQ:AWRE). Glenview State Bank Tru Dept owns 22,000 shares. Boston Private Wealth Lc, a Massachusetts-based fund reported 19,000 shares. Renaissance Ltd Liability Corporation stated it has 866,511 shares. Morgan Stanley stated it has 0% in Aware, Inc. (NASDAQ:AWRE). 463 are owned by Tower Rech Ltd (Trc). Vanguard Grp has invested 0% in Aware, Inc. (NASDAQ:AWRE). Royal Natl Bank Of Canada holds 0% or 243 shares. Gmt Cap has 24,600 shares. Css Ltd Liability Il has 0% invested in Aware, Inc. (NASDAQ:AWRE) for 24,737 shares. Ashfield Ptnrs Lc invested in 196,401 shares. California Public Employees Retirement reported 0% stake. Victory Cap Mgmt holds 2,561 shares or 0% of its portfolio.

Since January 1, 0001, it had 1 buying transaction, and 0 insider sales for $686,250 activity.

More notable recent Atrion Corporation (NASDAQ:ATRI) news were published by: Finance.Yahoo.com which released: “Should Atrion Corporation (NASDAQ:ATRI) Be Part Of Your Dividend Portfolio? – Yahoo Finance” on January 10, 2020, also Nasdaq.com with their article: “Atrion Enters Oversold Territory (ATRI) – Nasdaq” published on November 25, 2019, Finance.Yahoo.com published: “Be Sure To Check Out Atrion Corporation (NASDAQ:ATRI) Before It Goes Ex-Dividend – Yahoo Finance” on November 24, 2019. More interesting news about Atrion Corporation (NASDAQ:ATRI) were released by: Finance.Yahoo.com and their article: “Executive Chairman Emile Battat Just Bought Shares In Atrion Corporation (NASDAQ:ATRI) – Yahoo Finance” published on December 15, 2019 as well as Finance.Yahoo.com‘s news article titled: “How Should Investors Feel About Atrion Corporation’s (NASDAQ:ATRI) CEO Pay? – Yahoo Finance” with publication date: September 21, 2019.

Atrion Corporation develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products worldwide. The company has market cap of $1.30 billion. The companyÂ’s fluid delivery products include valves that promote infection control and needle safety, as well as for use in intubation, intravenous, catheter, and other applications in the fields of anesthesia and oncology. It has a 35.76 P/E ratio. The Company’s cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery.

The stock decreased 2.62% or $18.8 during the last trading session, reaching $699.99. About 9,207 shares traded or 1.14% up from the average. Atrion Corporation (ATRI) has declined 9.06% since January 16, 2019 and is downtrending. It has underperformed by 9.06% the S&P500. Some Historical ATRI News: 09/05/2018 – Atrion 1Q Rev $39.4M; 22/05/2018 – Atrion Corporation Declares Quarterly Cash Dividend; 09/05/2018 – ATRION 1Q REV. $39.4M; 03/04/2018 – Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel; 19/04/2018 – DJ Atrion Corporation, Inst Holders, 1Q 2018 (ATRI); 09/05/2018 – ATRION 1Q EPS $4.57; 19/03/2018 ATRION BOARD CHANGE VOTING STANDARD FOR ELECTING DIRECTORS

Roberts Glore & Co Inc Il holds 1.65% of its portfolio in Atrion Corporation for 3,464 shares. Thb Asset Management owns 9,559 shares or 1.38% of their US portfolio. Moreover, Kayne Anderson Rudnick Investment Management Llc has 0.78% invested in the company for 193,074 shares. The Tennessee-based Aldebaran Financial Inc. has invested 0.72% in the stock. Grisanti Capital Management Llc, a New York-based fund reported 1,080 shares.

Atrion Corporation (NASDAQ:ATRI) Institutional Positions Chart